WASHINGTON, September 29, 2024 — A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering ...
Use of an approved radionuclide therapy for difficult-to-treat meningioma was associated with substantially improved progression-free survival (PFS) compared with a historical benchmark, according to ...
Erin Bremmer was working on her graduate degree in clinical mental health counseling at Southern Oregon University in Ashland, Oregon, when the double vision she’d been experiencing now and then ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results